• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SPAG5 的转录和转录后调控异常,作为 YAP-TAZ-TEAD 的下游效应物,促进乳腺癌细胞增殖。

Aberrant transcriptional and post-transcriptional regulation of SPAG5, a YAP-TAZ-TEAD downstream effector, fuels breast cancer cell proliferation.

机构信息

Oncogenomic and Epigenetic Unit, Department of Research, Diagnosis and Innovative Technologies, IRCCS Regina Elena National Cancer Institute, Rome, Italy.

Clinical Trial Center, Biostatistics and Bioinformatics Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy.

出版信息

Cell Death Differ. 2021 May;28(5):1493-1511. doi: 10.1038/s41418-020-00677-9. Epub 2020 Nov 23.

DOI:10.1038/s41418-020-00677-9
PMID:33230261
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8166963/
Abstract

Sperm-associated antigen 5 (SPAG5) is an important driver of the cell mitotic spindle required for chromosome segregation and progression into anaphase. SPAG5 has been identified as an important proliferation marker and chemotherapy-sensitivity predictor, especially in estrogen receptor-negative breast cancer subtypes. Here, we report that SPAG5 is a direct target of miR-10b-3p, and its aberrantly high expression associates with poor disease-free survival in two large cohorts of breast cancer patients. SPAG5 depletion strongly impaired cancer cell cycle progression, proliferation, and migration. Interestingly, high expression of SPAG5 pairs with a YAP/TAZ-activated signature in breast cancer patients. Reassuringly, the depletion of YAP, TAZ, and TEAD strongly reduced SPAG5 expression and diminished its oncogenic effects. YAP, TAZ coactivators, and TEAD transcription factors are key components of the Hippo signaling pathway involved in tumor initiation, progression, and metastasis. Furthermore, we report that SPAG5 is a direct transcriptional target of TEAD/YAP/TAZ, and pharmacological targeting of YAP and TAZ severely reduces SPAG5 expression. Collectively, our data uncover an oncogenic feedback loop, comprising miR-10b-3p, SPAG5, and YAP/TAZ/TEAD, which fuels the aberrant proliferation of breast cancer.

摘要

精子相关抗原 5(SPAG5)是细胞有丝分裂纺锤体的重要驱动因子,对于染色体分离和进入后期至关重要。SPAG5 已被确定为重要的增殖标志物和化疗敏感性预测因子,尤其是在雌激素受体阴性的乳腺癌亚型中。在这里,我们报告 SPAG5 是 miR-10b-3p 的直接靶标,其异常高表达与两个大型乳腺癌患者队列的无病生存不良相关。SPAG5 的缺失强烈抑制了癌细胞的周期进展、增殖和迁移。有趣的是,在乳腺癌患者中,SPAG5 的高表达与 YAP/TAZ 激活的特征相关。令人欣慰的是,YAP、TAZ 和 TEAD 的缺失强烈降低了 SPAG5 的表达,并减弱了其致癌作用。YAP、TAZ 共激活因子和 TEAD 转录因子是 Hippo 信号通路的关键组成部分,该通路参与肿瘤的起始、进展和转移。此外,我们报告 SPAG5 是 TEAD/YAP/TAZ 的直接转录靶标,YAP 和 TAZ 的药理学靶向严重降低了 SPAG5 的表达。总之,我们的数据揭示了一个致癌的反馈回路,包括 miR-10b-3p、SPAG5 和 YAP/TAZ/TEAD,该回路推动了乳腺癌的异常增殖。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8973/8166963/458756bdc453/41418_2020_677_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8973/8166963/c2223507652c/41418_2020_677_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8973/8166963/2672bb8162b9/41418_2020_677_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8973/8166963/6213e288206b/41418_2020_677_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8973/8166963/469d9485df4f/41418_2020_677_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8973/8166963/294d4590bd7f/41418_2020_677_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8973/8166963/a46ac9a3cfd6/41418_2020_677_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8973/8166963/458756bdc453/41418_2020_677_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8973/8166963/c2223507652c/41418_2020_677_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8973/8166963/2672bb8162b9/41418_2020_677_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8973/8166963/6213e288206b/41418_2020_677_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8973/8166963/469d9485df4f/41418_2020_677_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8973/8166963/294d4590bd7f/41418_2020_677_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8973/8166963/a46ac9a3cfd6/41418_2020_677_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8973/8166963/458756bdc453/41418_2020_677_Fig7_HTML.jpg

相似文献

1
Aberrant transcriptional and post-transcriptional regulation of SPAG5, a YAP-TAZ-TEAD downstream effector, fuels breast cancer cell proliferation.SPAG5 的转录和转录后调控异常,作为 YAP-TAZ-TEAD 的下游效应物,促进乳腺癌细胞增殖。
Cell Death Differ. 2021 May;28(5):1493-1511. doi: 10.1038/s41418-020-00677-9. Epub 2020 Nov 23.
2
YAP/TAZ Transcriptional Coactivators Create Therapeutic Vulnerability to Verteporfin in EGFR-mutant Glioblastoma.YAP/TAZ 转录共激活因子为 EGFR 突变型脑胶质瘤对维替泊芬治疗敏感创造了条件。
Clin Cancer Res. 2021 Mar 1;27(5):1553-1569. doi: 10.1158/1078-0432.CCR-20-0018. Epub 2020 Nov 10.
3
A Novel Irreversible TEAD Inhibitor, SWTX-143, Blocks Hippo Pathway Transcriptional Output and Causes Tumor Regression in Preclinical Mesothelioma Models.一种新型不可逆 TEAD 抑制剂 SWTX-143 可阻断 Hippo 通路转录输出并在间皮瘤临床前模型中引起肿瘤消退。
Mol Cancer Ther. 2024 Jan 3;23(1):3-13. doi: 10.1158/1535-7163.MCT-22-0681.
4
The transcriptional regulators TAZ and YAP direct transforming growth factor β-induced tumorigenic phenotypes in breast cancer cells.转录调节因子 TAZ 和 YAP 指导转化生长因子 β 诱导的乳腺癌细胞中的肿瘤发生表型。
J Biol Chem. 2014 May 9;289(19):13461-74. doi: 10.1074/jbc.M113.529115. Epub 2014 Mar 19.
5
Convergence of YAP/TAZ, TEAD and TP63 activity is associated with bronchial premalignant severity and progression.YAP/TAZ、TEAD 和 TP63 活性的汇聚与支气管前恶性严重程度和进展相关。
J Exp Clin Cancer Res. 2023 May 8;42(1):116. doi: 10.1186/s13046-023-02674-5.
6
Discovery of a cryptic site at the interface 2 of TEAD - Towards a new family of YAP/TAZ-TEAD inhibitors.发现 TEAD-界面 2 的隐匿位点——迈向 YAP/TAZ-TEAD 抑制剂的新家族。
Eur J Med Chem. 2021 Dec 15;226:113835. doi: 10.1016/j.ejmech.2021.113835. Epub 2021 Sep 6.
7
Hippo pathway inhibition by blocking the YAP/TAZ-TEAD interface: a patent review.通过阻断 YAP/TAZ-TEAD 界面抑制 Hippo 通路:专利述评。
Expert Opin Ther Pat. 2018 Dec;28(12):867-873. doi: 10.1080/13543776.2018.1549226. Epub 2018 Dec 2.
8
SPAG5 upregulation contributes to enhanced c-MYC transcriptional activity via interaction with c-MYC binding protein in triple-negative breast cancer.SPAG5 上调通过与三阴性乳腺癌中 c-MYC 结合蛋白相互作用促进 c-MYC 转录活性。
J Hematol Oncol. 2019 Feb 8;12(1):14. doi: 10.1186/s13045-019-0700-2.
9
Ski regulates Hippo and TAZ signaling to suppress breast cancer progression.Ski通过调节Hippo和TAZ信号通路来抑制乳腺癌进展。
Sci Signal. 2015 Feb 10;8(363):ra14. doi: 10.1126/scisignal.2005735.
10
SS18-SSX-Dependent YAP/TAZ Signaling in Synovial Sarcoma.滑膜肉瘤中 SS18-SSX 依赖性 YAP/TAZ 信号通路。
Clin Cancer Res. 2019 Jun 15;25(12):3718-3731. doi: 10.1158/1078-0432.CCR-17-3553. Epub 2019 Feb 27.

引用本文的文献

1
Unraveling the Hippo pathway: YAP/TAZ as central players in cancer metastasis and drug resistance.解析河马通路:YAP/TAZ在癌症转移和耐药性中扮演核心角色。
EXCLI J. 2025 Jun 6;24:612-637. doi: 10.17179/excli2025-8351. eCollection 2025.
2
Targeting of mutant-p53 and MYC as a novel strategy to inhibit oncogenic SPAG5 activity in triple negative breast cancer.靶向突变型 p53 和 MYC 作为一种抑制三阴性乳腺癌中致癌 SPAG5 活性的新策略。
Cell Death Dis. 2024 Aug 20;15(8):603. doi: 10.1038/s41419-024-06987-x.
3
SPAG5 deficiency activates autophagy to reduce atherosclerotic plaque formation in ApoE mice.

本文引用的文献

1
MicroRNA-138 is a Prognostic Biomarker for Triple-Negative Breast Cancer and Promotes Tumorigenesis via TUSC2 repression.微小 RNA-138 是三阴性乳腺癌的预后生物标志物,并通过抑制 TUSC2 促进肿瘤发生。
Sci Rep. 2019 Sep 3;9(1):12718. doi: 10.1038/s41598-019-49155-4.
2
The Myb-MuvB Complex Is Required for YAP-Dependent Transcription of Mitotic Genes.Myb-MuvB 复合物是 YAP 依赖性有丝分裂基因转录所必需的。
Cell Rep. 2019 Jun 18;27(12):3533-3546.e7. doi: 10.1016/j.celrep.2019.05.071.
3
Hippo Pathway in Cancer: Aberrant Regulation and Therapeutic Opportunities.
SPAG5 缺乏会激活自噬,从而减少 ApoE 小鼠的动脉粥样硬化斑块形成。
BMC Cardiovasc Disord. 2024 May 28;24(1):275. doi: 10.1186/s12872-024-03945-5.
4
Sperm-Associated Antigen 5 Knockout Reduces Doxorubicin and Docetaxel Resistance in Triple-Negative Breast Cancer MDA-MB-231 and BT549 Cells.精子相关抗原5基因敲除降低三阴性乳腺癌MDA-MB-231和BT549细胞对阿霉素和多西他赛的耐药性
Cancers (Basel). 2024 Mar 24;16(7):1269. doi: 10.3390/cancers16071269.
5
The role of alternative pre-mRNA splicing in cancer progression.可变前体信使核糖核酸剪接在癌症进展中的作用。
Cancer Cell Int. 2023 Oct 24;23(1):249. doi: 10.1186/s12935-023-03094-3.
6
YAP/TAZ: Molecular pathway and disease therapy.YAP/TAZ:分子途径与疾病治疗
MedComm (2020). 2023 Aug 9;4(4):e340. doi: 10.1002/mco2.340. eCollection 2023 Aug.
7
The Hippo Pathway Effectors YAP/TAZ-TEAD Oncoproteins as Emerging Therapeutic Targets in the Tumor Microenvironment.河马通路效应因子YAP/TAZ-TEAD癌蛋白作为肿瘤微环境中新兴的治疗靶点。
Cancers (Basel). 2023 Jul 2;15(13):3468. doi: 10.3390/cancers15133468.
8
Prognostic and immune implications of a novel 7-methylguanosine-related microRNA signature in breast invasive carcinoma: from exploration to validation.新型 7-甲基鸟苷相关 microRNA 特征在乳腺浸润性癌中的预后和免疫意义:从探索到验证。
J Cancer Res Clin Oncol. 2023 Sep;149(11):9105-9128. doi: 10.1007/s00432-023-04849-1. Epub 2023 May 12.
9
Identification of key genes associated with cancer stem cell characteristics in Wilms' tumor based on bioinformatics analysis.基于生物信息学分析的肾母细胞瘤中与癌症干细胞特征相关的关键基因鉴定
Ann Transl Med. 2022 Nov;10(22):1204. doi: 10.21037/atm-22-4477.
10
The splicing factor SF3B4 drives proliferation and invasion in cervical cancer by regulating SPAG5.剪接因子SF3B4通过调控SPAG5促进宫颈癌的增殖和侵袭。
Cell Death Discov. 2022 Jul 19;8(1):326. doi: 10.1038/s41420-022-01120-3.
癌症中的河马通路:异常调控与治疗机遇
Trends Cancer. 2019 May;5(5):297-307. doi: 10.1016/j.trecan.2019.04.001. Epub 2019 May 16.
4
SPAG5 contributes to the progression of gastric cancer by upregulation of Survivin depend on activating the wnt/β-catenin pathway.SPAG5 通过上调 Survivin 依赖激活 wnt/β-catenin 通路促进胃癌的进展。
Exp Cell Res. 2019 Jun 1;379(1):83-91. doi: 10.1016/j.yexcr.2019.03.024. Epub 2019 Mar 21.
5
SPAG5 upregulation contributes to enhanced c-MYC transcriptional activity via interaction with c-MYC binding protein in triple-negative breast cancer.SPAG5 上调通过与三阴性乳腺癌中 c-MYC 结合蛋白相互作用促进 c-MYC 转录活性。
J Hematol Oncol. 2019 Feb 8;12(1):14. doi: 10.1186/s13045-019-0700-2.
6
Sperm-associated antigen 5 is a potential biomarker for poor prognosis in breast cancer.精子相关抗原5是乳腺癌预后不良的潜在生物标志物。
Oncol Lett. 2019 Jan;17(1):1146-1152. doi: 10.3892/ol.2018.9729. Epub 2018 Nov 19.
7
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
8
SPAG5 interacts with CEP55 and exerts oncogenic activities via PI3K/AKT pathway in hepatocellular carcinoma.SPAG5 通过 PI3K/AKT 通路与 CEP55 相互作用,在肝癌中发挥致癌活性。
Mol Cancer. 2018 Aug 8;17(1):117. doi: 10.1186/s12943-018-0872-3.
9
Agave negatively regulates YAP and TAZ transcriptionally and post-translationally in osteosarcoma cell lines.龙舌兰在骨肉瘤细胞系中通过转录和翻译后水平负调控 YAP 和 TAZ。
Cancer Lett. 2018 Oct 1;433:18-32. doi: 10.1016/j.canlet.2018.06.021. Epub 2018 Jun 19.
10
Multifaceted regulation and functions of YAP/TAZ in tumors (Review).YAP/TAZ 在肿瘤中的多方面调控和功能(综述)。
Oncol Rep. 2018 Jul;40(1):16-28. doi: 10.3892/or.2018.6423. Epub 2018 May 8.